Enzo Biochem, Inc.:
$100m revs in F18. Pioneer in molecular diagnostics (Dx), leading convergence of clinical laboratories, life sciences and IP through devt of unique Dx platform technologies providing numerous advantages over previous standards.
Healthcare/Medical Diagnostics & Research
US - Middle Atlantic
100MM - 500MM
527 Madison Avenue
New York, NY NY 10022
Top 10 Holders of Enzo Biochem, Inc.
Ownership data is sourced through FactSet.
Stock Market Data
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by